NEW YORK STATE COMMON RETIREMENT FUND - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 148 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2020. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$242
-18.2%
44,396
+0.8%
0.00%
Q2 2023$296
-40.2%
44,063
-21.4%
0.00%
-100.0%
Q1 2023$495
-17.4%
56,086
-28.5%
0.00%0.0%
Q4 2022$599
-99.9%
78,411
-0.1%
0.00%0.0%
Q3 2022$559,000
-10.8%
78,462
+1.2%
0.00%0.0%
Q2 2022$627,000
-59.4%
77,526
-30.3%
0.00%
-50.0%
Q1 2022$1,544,000
-55.2%
111,236
-9.4%
0.00%
-33.3%
Q4 2021$3,444,000
-17.4%
122,7360.0%0.00%
-25.0%
Q3 2021$4,172,000
-16.8%
122,7360.0%0.00%
-20.0%
Q2 2021$5,015,000
-3.2%
122,736
-4.7%
0.01%
-16.7%
Q1 2021$5,183,000
-58.6%
128,744
-39.1%
0.01%
-57.1%
Q4 2020$12,506,000
+16.2%
211,506
-4.4%
0.01%
+7.7%
Q3 2020$10,762,000
-1.9%
221,306
-2.4%
0.01%
-7.1%
Q2 2020$10,973,000
+179.7%
226,806
+60.6%
0.01%
+133.3%
Q1 2020$3,923,000
+339.3%
141,206
+373.3%
0.01%
+500.0%
Q4 2019$893,000
+110.6%
29,836
+117.2%
0.00%0.0%
Q3 2019$424,000
+21100.0%
13,736
+27372.0%
0.00%
Q2 2019$2,000500.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders